Characterization of de novo microdeletions involving 17q11.2q12 identified through chromosomal comparative genomic hybridization

High‐resolution array‐comparative genome hybridization (CGH) is a powerful tool for detection of submicroscopic chromosome deletions and duplications. We describe two patients with mild mental retardation (MR) and de novo microdeletions of 17q11.2q12. Although the deletions did not involve the neurofibromatosis type 1 (NF1) gene, they overlap with long‐range deletions of the NF1 region which have been encountered in a small group of NF1 patients with more severe MR. Given the overlap of the deletions in our two patients with the large‐sized NF1 microdeletions but not with the more frequent and smaller NF1 deletions, we hypothesize that more than one gene in the 17q11.2q12 region may be involved in MR. We discuss candidate genes for MR within this interval that was precisely defined through array‐CGH analysis.

[1]  Z. Ou,et al.  Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation , 2007, American journal of medical genetics. Part A.

[2]  Z. Ou,et al.  Clinical Implementation of Chromosomal Microarray Analysis: Summary of 2513 Postnatal Cases , 2007, PloS one.

[3]  K. Gunderson,et al.  High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. , 2006, Genome research.

[4]  Pawel Stankiewicz,et al.  Genomic disorders : the genomic basis of disease , 2006 .

[5]  L. Larizza,et al.  Mutations and novel polymorphisms in coding regions and UTRs of CDK5R1 and OMG genes in patients with non-syndromic mental retardation , 2006, Neurogenetics.

[6]  Han G Brunner,et al.  Identification of disease genes by whole genome CGH arrays. , 2005, Human molecular genetics.

[7]  Ton Feuth,et al.  Diagnostic genome profiling in mental retardation. , 2005, American journal of human genetics.

[8]  Chad A Shaw,et al.  Development and validation of a CGH microarray for clinical cytogenetic diagnosis , 2005, Genetics in Medicine.

[9]  Hongyu Zhao,et al.  Erratum to "A statistical method to detect chromosomal regions with DNA copy number alterations using SNP-array-based CGH data": [Comput. Biol. Chem. 29(2005) 47-54] , 2005, Comput. Biol. Chem..

[10]  Hongyu Zhao,et al.  A statistical method to detect chromosomal regions with DNA copy number alterations using SNP-array-based CGH data , 2005, Comput. Biol. Chem..

[11]  Martin Offringa,et al.  Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness , 2005, European Journal of Human Genetics.

[12]  Kyong-Tai Kim,et al.  Activation of cyclin-dependent kinase 5 is involved in axonal regeneration , 2004, Molecular and Cellular Neuroscience.

[13]  L. Tsai,et al.  Cyclin-Dependent Kinase 5 Phosphorylates the N-Terminal Domain of the Postsynaptic Density Protein PSD-95 in Neurons , 2004, The Journal of Neuroscience.

[14]  R. Tenconi,et al.  Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2 , 2004, Journal of Medical Genetics.

[15]  L. Tsai,et al.  Layering defect in p35 deficiency is linked to improper neuronal-glial interaction in radial migration , 2003, Nature Neuroscience.

[16]  David S. Park,et al.  Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Nancy Y. Ip,et al.  Cdk5: A New Player at Synapses , 2003, Neurosignals.

[18]  Minh Dang Nguyen,et al.  Cyclin-Dependent Kinase 5 in Amyotrophic Lateral Sclerosis , 2003, Neurosignals.

[19]  M. Ahlijanian,et al.  Role of cdk5 in the Pathogenesis of Alzheimer’s Disease , 2003, Neurosignals.

[20]  J. Radulovic,et al.  Cyclin-Dependent Kinase 5 Is Required for Associative Learning , 2002, The Journal of Neuroscience.

[21]  M. Brand,et al.  Cloning and expression of Ventrhoid, a novel vertebrate homologue of the Drosophila EGF pathway gene rhomboid , 2002, Mechanisms of Development.

[22]  A. Kulkarni,et al.  Cyclin‐dependent kinase 5 prevents neuronal apoptosis by negative regulation of c‐Jun N‐terminal kinase 3 , 2002, The EMBO journal.

[23]  H. Leonard,et al.  The epidemiology of mental retardation: challenges and opportunities in the new millennium. , 2002, Mental retardation and developmental disabilities research reviews.

[24]  D. Flaherty,et al.  Phosphorylation of human tau protein by microtubule‐associated kinases: GSK3β and cdk5 are key participants , 2000, Journal of neuroscience research.

[25]  D. Horn,et al.  A common set of at least 11 functional genes is lost in the majority of NF1 patients with gross deletions. , 2000, Genomics.

[26]  M. Weaver,et al.  NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. , 2000, Human molecular genetics.

[27]  L. Tsai,et al.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration , 1999, Nature.

[28]  G. Sobue,et al.  Zep: A novel zinc finger protein containing a large proline-rich domain. , 1998, Journal of biochemistry.

[29]  C. Schwartz,et al.  Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1. , 1998, Journal of medical genetics.

[30]  D. Cooper,et al.  Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay , 1998, Human Genetics.

[31]  M. Weaver,et al.  Familial neurofibromatosis 1 microdeletions: cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata. , 1997, American journal of medical genetics.

[32]  H. Moser,et al.  Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders , 1997, Nature Genetics.

[33]  L. Shaffer,et al.  Diagnosis of CMT1A duplications and HNPP deletions by interphase FISH: implications for testing in the cytogenetics laboratory. , 1997, American journal of medical genetics.

[34]  B. Hyman,et al.  BNaC1 and BNaC2 constitute a new family of human neuronal sodium channels related to degenerins and epithelial sodium channels. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Manoukian,et al.  Characterization of a cytogenetic 17q11.2 deletion in an NF1 patient with a contiguous gene syndrome , 1996, Human Genetics.

[36]  V. P. Johnson,et al.  The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization. , 1996, Cytogenetics and cell genetics.

[37]  B J Williams,et al.  Comparative genomic hybridization. , 1996, Methods in molecular medicine.

[38]  B. Korf,et al.  Deletion of the entire NF1 gene detected by the FISH: four deletion patients associated with severe manifestations. , 1995, American journal of medical genetics.

[39]  R. Aebersold,et al.  A brain-specific activator of cyclin-dependent kinase 5 , 1994, Nature.

[40]  W. Burke,et al.  Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. , 1994, American journal of human genetics.

[41]  E. Mandelkow,et al.  Abnormal Alzheimer‐like phosphorylation of tau‐protein by cyclin‐dependent kinases cdk2 and cdk5 , 1993, FEBS letters.

[42]  W. Burke,et al.  Large de novo DNA deletion in a patient with sporadic neurofibromatosis 1, mental retardation, and dysmorphism. , 1992, Journal of medical genetics.

[43]  H. Scholte,et al.  Acetyl-CoA carboxylase deficiency: an inborn error of de novo fatty acid synthesis. , 1981, The New England journal of medicine.